Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.006 AUD | +20.00% | 0.00% | +20.00% |
Mar. 05 | Invion's Anti-Cancer Drug Logs Postive Preclinical Trial Results | MT |
Feb. 27 | Invion Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+20.00% | 20.86M | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- IVX Stock
- News Invion Limited
- Invion's Cancer Treatment Patent Application Published